Iwona Cicha

Prof. Dr. Iwona Cicha

Cardiovascular Nanomedicine Unit, Section of Experimental Oncology and Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Erlangen, Germany
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BSBapi Sarker
Bapi Sarker
RSRaminder Singh
Raminder Singh
RSRaquel Silva
Raquel Silva
JRJudith A. Roether
Judith A. Roether
JKJoachim Kaschta
Joachim Kaschta
Aldo R. BoccacciniAldo R. Boccaccini
Aldo R. Boccaccini
Due to the relatively poor cell-material interaction of alginate hydrogel, alginate-gelatin crosslinked (ADA-GEL) hydrogel was synthesized through covalent crosslinking of alginate di-aldehyde (ADA) with gelatin that supported cell attachment, spreading and proliferation. This study highlights the evaluation of the physico-chemical properties of synthesized ADA-GEL hydrogels of different compositions compared to alginate in the form of films. Moreover, in vitro cell-material interaction on ADA-GEL hydrogels of different compositions compared to alginate was investigated by using normal human dermal fibroblasts. Viability, attachment, spreading and proliferation of fibroblasts were significantly increased on ADA-GEL hydrogels compared to alginate. Moreover, in vitro cytocompatibility of ADA-GEL hydrogels was found to be increased with increasing gelatin content. These findings indicate that ADA-GEL hydrogel is a promising material for the biomedical applications in tissue-engineering and regeneration.

1 September 2004 in Atherosclerosis
Verified
Journal Article
Closed access
AYAtilla Yilmaz
Atilla Yilmaz
MLMarlene Lochno
Marlene Lochno
FTFriedemann Traeg
Friedemann Traeg
Iwona CichaIwona Cicha
Iwona Cicha
CRChristine Reiss
Christine Reiss
CGChristoph D Garlichs
Christoph D Garlichs

8 September 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
RFRalf Friedrich
Ralf Friedrich
Iwona CichaIwona Cicha
Iwona Cicha
CAChristoph Alexiou
Christoph Alexiou
In recent years, many promising nanotechnological approaches to biomedical research have been developed in order to increase implementation of regenerative medicine and tissue engineering in clinical practice. In the meantime, the use of nanomaterials for the regeneration of diseased or injured tissues is considered advantageous in most areas of medicine. In particular, for the treatment of cardiovascular, osteochondral and neurological defects, but also for the recovery of functions of other organs such as kidney, liver, pancreas, bladder, urethra and for wound healing, nanomaterials are increasingly being developed that serve as scaffolds, mimic the extracellular matrix and promote adhesion or differentiation of cells. This review focuses on the latest developments in regenerative medicine, in which iron oxide nanoparticles (IONPs) play a crucial role for tissue engineering and cell therapy. IONPs are not only enabling the use of non-invasive observation methods to monitor the therapy, but can also accelerate and enhance regeneration, either thanks to their inherent magnetic properties or by functionalization with bioactive or therapeutic compounds, such as drugs, enzymes and growth factors. In addition, the presence of magnetic fields can direct IONP-labeled cells specifically to the site of action or induce cell differentiation into a specific cell type through mechanotransduction.

1 March 2018 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
HUHarald Unterweger
Harald Unterweger
László DézsiLászló Dézsi
László Dézsi
JMJasmin Matuszak
Jasmin Matuszak
CJChristina Janko
Christina Janko
MPMarina Poettler
Marina Poettler
Iwona CichaIwona Cicha
Iwona Cicha
Background: Rising criticism of currently available contrast agents for magnetic resonance imaging, either due to their side effects or limited possibilities in terms of functional imaging, evoked the need for safer and more versatile agents. We previously demonstrated the suitability of novel dextran-coated superparamagnetic iron oxide nanoparticles (SPIONDex) for biomedical applications in terms of safety and biocompatibility. Methods: In the present study, we investigated the size-dependent cross-linking process of these particles as well as the size dependency of their imaging properties. For the latter purpose, we adopted a simple and easy-to-perform experiment to estimate the relaxivity of the particles. Furthermore, we performed an extensive analysis of the particles’ storage stability under different temperature conditions, showing their superb stability and the lack of any signs of agglomeration or sedimentation during a 12 week period. Results: Independent of their size, SPIONDex displayed no irritation potential in a chick chorioallantoic membrane assay. Cell uptake studies of ultra-small (30 nm) SPIONDex confirmed their internalization by macrophages, but not by non-phagocytic cells. Additionally, complement activation-related pseudoallergy (CARPA) experiments in pigs treated with ultra-small SPIONDex indicated the absence of hypersensitivity reactions. Conclusion: These results emphasize the exceptional safety of SPIONDex, setting them apart from the existing SPION-based contrast agents and making them a very promising candidate for further clinical development.

24 February 2009 in BioFactors
Verified
Journal Article
Closed access
PDF file
Iwona CichaIwona Cicha
Iwona Cicha
MGMargarete Goppelt‐Struebe
Margarete Goppelt‐Struebe

1 October 2014 in International Journal of Nanomedicine
Verified
Journal Article
Open access
JZJan Zaloga
Jan Zaloga
CJChristina Janko
Christina Janko
JNJohannes Nowak
Johannes Nowak
JMJasmin Matuszak
Jasmin Matuszak
SKSabine Knaup
Sabine Knaup
SDStephan Duerr
Stephan Duerr
The promising potential of superparamagnetic iron oxide nanoparticles (SPIONs) in various nanomedical applications has been frequently reported. However, although many different synthesis methods, coatings, and functionalization techniques have been described, not many core-shell SPION drug delivery systems are available for clinicians at the moment. Here, bovine serum albumin was adsorbed onto lauric acid-stabilized SPIONs. The agglomeration behavior, zeta potential, and their dependence on the synthesis conditions were characterized with dynamic light scattering. The existence and composition of the core-shell-matrix structure was investigated by transmission electron microscopy, Fourier transform infrared spectroscopy, and zeta potential measurements. We showed that the iron oxide cores form agglomerates in the range of 80 nm. Moreover, despite their remarkably low tendency to aggregate even in a complex media like whole blood, the SPIONs still maintained their magnetic properties and were well attractable with a magnet. The magnetic properties were quantified by vibrating sample magnetometry and a superconducting quantum interference device. Using flow cytometry, we further investigated the effects of the different types of nanoparticle coating on morphology, viability, and DNA integrity of Jurkat cells. We showed that by addition of bovine serum albumin, the toxicity of nanoparticles is greatly reduced. We also investigated the effect of the particles on the growth of primary human endothelial cells to further demonstrate the biocompatibility of the particles. As proof of principle, we showed that the hybrid-coated particles are able to carry payloads of up to 800 µg/mL of the cytostatic drug mitoxantrone while still staying colloidally stable. The drug-loaded system exhibited excellent therapeutic potential in vitro, exceeding that of free mitoxantrone. In conclusion, we have synthesized a biocompatible ferrofluid that shows great potential for clinical application. The synthesis is straightforward and reproducible and thus easily translatable into a good manufacturing practice environment.